Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;31(11):1488-94.
doi: 10.1007/s00134-005-2697-y. Epub 2005 Sep 7.

Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

Affiliations

Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

Elpis Giantsou et al. Intensive Care Med. 2005 Nov.

Abstract

Objective: To compare the causative pathogens of early-onset and late-onset ventilator-associated pneumonia (VAP) diagnosed by bronchoalveolar lavage quantitative cultures. Most previous reports have been based on endotracheal aspirate cultures and gave uncertain findings.

Design: Prospective evaluation of consecutive patients with clinical suspicion for VAP.

Setting: Multidisciplinary intensive care unit of a university hospital.

Patients and participants: During a 3-year period 473 patients with clinical suspicion of VAP entered the study. Diagnosis of VAP was confirmed by cultures of bronchoalveolar lavage (> 10(4) cfu/ml) specimens in 408 patients.

Interventions: Protected bronchoalveolar lavage samples were taken. Initial antibiotic therapy was modified upon bronchoalveolar lavage culture results.

Measurements and results: Among 408 patients 191 had early-onset (< 7 days mechanical ventilation) and 217 late-onset (> or = 7 days) VAP. Potentially multiresistant bacteria, mainly Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), were the most commonly isolated pathogens in both types of VAP. No difference was noted in the contribution of potentially multiresistant pathogens (79% vs. 85%), P. aeruginosa (42% vs. 47%), or MRSA (33% vs. 30%) between early-onset and late-onset VAP. Initial antibiotic therapy was modified in 58% of early-onset VAP episodes and in 36% of late-onset VAP episodes. No difference in mortality was found between the two types of VAP.

Conclusions: Both early-onset and late-onset VAP were mainly caused by potentially multiresistant bacteria, most commonly P. aeruginosa and MRSA. Antimicrobial agents against these pathogens should be prescribed empirically, at least in our institution.

PubMed Disclaimer

Comment in

References

    1. Chest. 2001 Sep;120(3):955-70 - PubMed
    1. Curr Opin Pulm Med. 1997 Mar;3(2):120-4 - PubMed
    1. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):855-64 - PubMed
    1. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1249-56 - PubMed
    1. Eur Respir J. 2003 Dec;22(6):876-82 - PubMed